Roselabs Bioscience and Roselabs Polymers, a part of the Roselabs Group, has invested Rs 400 crore in setting up the pre-filled syringe (PFS) making facility in Ahmedabad, Gujarat.
The project has been spread across 90,000 sq ft and it has 82 million per annum glass PFS production capacity and 1.1 million per day polymer PFS production capacity.
Roselabs has already commenced commercial production in January 2013.
The company is expecting to get regulatory approvals from 35-40 countries, mainly from Latin America, South East Asia and Africa, by December 2013.
The World Health Organization-Good Manufacturing Practice (WHO-GMP) has already granted its approval for the facility.
Currently, Roselabs is working for five multi-national drug makers for their patented products.